Regenerative medicine (RM) is one of the new portfolios created in response to the current military medical needs to treat traumatically injured tissues resulting from combat or battlefield wounds. This young and promising field has already achieved early success in the regeneration of several tissues and organs for repair or replacement.
RM encompasses many novel approaches for the treatment of damaged tissues and organs by using therapies that prompt the body to autonomously regenerate, and by using autologous cells from the patient's body to seed on biodegradable scaffolds for the creation of engineered organs for therapy. These innovations are possible because of several key advances, including the development of systems that can reliably nurture cells as they grow and divide, the discovery of growth factors that foster cell proliferation in vitro, and the fabrication of biomaterial scaffolds for tissue generation in three-dimensions. Thus, projects within this portfolio seek to advance the sciences and technologies in tissue engineering and stem cell research to help replace or re-grow lost, damaged, or diseased tissues, organs, or limbs. This also includes projects that seek to improve wound healing and/or to repair damaged tissues through the use of cell therapy and/or gene therapy.
For more information please contact the Program Manager at: regenMed@tatrc.org